$8.33 -0.26 (-3.03%)
2/10/2012 4:00 PM

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Featured Broker Partners


Advertisement